DRD4 and neoplasm: DRD4, a key dopamine receptor, relays light–dark signals in the retina to synchronise intracellular clocks [44]; in CRC, aberrant DRD4 up-regulation activates the TGF-β pathway, enhancing tumour migration and invasion [45].